Genovefa Polychronidou

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

George Fountzilas, Christos Valavanis, Vassiliki Kotoula et al. · Journal of Translational Medicine · 2012 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients

Eirini Katodritou, Evangelos Terpos, Argiris Symeonidis et al. · American Journal of Hematology · 2014 · 69 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Kyriaki Pliarchopoulou, Konstantine T. Kalogeras, Ralf Kronenwett et al. · Cancer Chemotherapy and Pharmacology · 2012 · 55 citations

Medicine, Molecular Genetics, Oncology +11

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis et al. · Annals of Hematology · 2015 · 54 citations

Medicine, Hematology, Oncology +12

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer

Elena Fountzilas, Vassiliki Kotoula, George Pentheroudakis et al. · ESMO Open · 2019 · 51 citations · Full text

Medicine, Oncology, Pathology +14